Search
for
Sort by
Research 31–60 of 718
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol.
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Mucocutaneous reactions to chemotherapy
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Pinnal Diseases
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Efectos adversos dermatológicos con uso de litio
- Cutaneous drug reactions
- Acute Hair Loss 3 Years after Bone Marrow Transplant
- Ashy Dermatosis
- British Society for Dermatopathology
- A generalized reticulate eruption with scarring alopecia, vulvovaginitis, keratoderma, and 20-nail dystrophy in a 70-year-old woman
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Dermatological Manifestations of COVID-19 Patients
- Comparison of patients’ diagnoses in a dermatology outpatient clinic during the COVID‐19 pandemic period and pre‐pandemic period
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Secondary Syphilis in a 12-Year-Old Girl Misdiagnosed as Pityriasis lichenoides et varioliformis acuta: A Case Report
- Linear Lichen Planopilaris of the Trunk: First Report of a Case
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Atypical Presentation of Lichen Planopilaris: Presentation of Two Cases and Review
- The color of skin: white diseases of the skin, nails, and mucosa
- Black hair dye dermatitis: Still a major skin problem and commonly mimicking chronic actinic dermatitis
- Immunologic adverse reactions of β-blockers and the skin (Review)
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Folliculotropic non-alopecic secondary syphilis